DrugDashboards

Epinephrine

Epinephrine · EPINEPHRINE .15 mg/.3mL · Injection · Intramuscular; Subcutaneous · Bryant Ranch Prepack

NDC 63629-8801-01 · 2 CONTAINER in 1 CARTON / 1 SYRINGE in 1 CONTAINER / .3 mL in 1 SYRINGE · ANDA · View full market →

The short version

25 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 4× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 00093-5985-27) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$144.22per unit
middle half $128.01–$211.94 · 5,332 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $144.22
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
97%of plans cover it
tier 3 · prior auth 0% · step therapy 0% · qty limit 74%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for epinephrine (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $206.21 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA090589
TE code
AB
Approval date
Aug 16, 2018
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Epinephrine (Injection)

LabelerStrengthFirst seenLast seen
Asclemed USA, Inc.EPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE 1 mg/mLJul 23, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 3, 2026
Par Health USA, LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 3, 2026
Remedyrepack Inc.EPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
A-S Medication SolutionsEPINEPHRINE .15 mg/.3mLJul 15, 2026Sep 2, 2026
Advanced Rx Pharmacy of Tennessee, LLCEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
American Regent, Inc.EPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCEPINEPHRINE .15 mg/.15mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals Private LimitedEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Asclemed Usa Inc.EPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.EPINEPHRINE .15 mg/.15mLJul 15, 2026Sep 2, 2026
BPI Labs, LLCEPINEPHRINE 30 mg/30mLJul 15, 2026Sep 2, 2026
Bryant Ranch PrepackEPINEPHRINE .15 mg/.3mLJul 15, 2026Sep 2, 2026
Catalent Indiana, LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Catalent Indiana, LLCEPINEPHRINE .5 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.EPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE .15 mg/.15mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE .15 mg/.3mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.EPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
International Medication Systems, LimitedEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
International Medication Systems, LimitedEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCEPINEPHRINE .15 mg/.3mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLC.EPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Novo Nordisk Production Belgium SAEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Redpharm DrugEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.EPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.EPINEPHRINE .15 mg/.15mLJul 15, 2026Sep 2, 2026
Sina Health IncEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.EPINEPHRINE .5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Epinephrine — NDC 63629-8801-01," retrieved September 3, 2026, https://drugdashboards.com/drug/63629880101.

Free to cite with attribution — see how the data is put together.